Modulation of peripheral blood lymphocyte subsets during methylprednisolone pulse therapy

Tokai Journal of Experimental and Clinical Medicine

Volumn 21, Issue 2, 1996, Pages 77-88

  Fukuda, Ryuki ^a   Horiki, Terumi ^a   Sasao, Tamotsu ^a   Kawada, Hiroshi ^a   Ichikawa, Yukinobu ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Lymphocyte subsets; Methylprednisolone; Pulse therapy; Systemic lupus erythematosus

Indexed keywords

CD11 ANTIGEN; CD16 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG THERAPY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; MALE; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; PROGNOSIS; RELAPSING POLYCHONDRITIS; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RHEUMATIC DISEASES;

EID: 0030422776     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345: 99, 1995
2. Ballou SP, Khan MA, Kushner I. Intravenous pulse methylprednisolone followed by alternate day corticosteroid therapy in lupus erythematosus: A prospective evaluation. J Rheumatol 12: 944, 1985.
3. Caldwell CW, Bridges AJ, Walker SE, et al. A controlled study of lymphocyte subsets in rheumatoid arthritis. Clin Immunol Immunopathol 63: 237, 1992.
4. Cathcart ES, Scheinberg MA, Idelson BA, Couser WG. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet I: 163, 1976.
5. Erkeller-Yüsel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 2: 227, 1993.
6. Fan PT, Yu DTY, Clements PJ, Fowlston S, Eisman J, Bluestone R. Effect of corticosteroids on the human immune response: comparison of one and three daily 1g intravenous pulses of methylprednisolone. J Lab Clin Med 91:625, 1978.
7. Ferrari A, Pasqualetti D, del Bianco P, Gandolfo GM, Chistolini A, Mazzucconi MG. Prednisolone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications. Haematologica 76: 342, 1991
8. Forster PJG, Grindulis KA, Neumann V, Hubball S, McConkey B. High dose intravenous methylprednisolone in rheumatoid arthritis. Ann Rheum Dis 41: 444, 1982.
9. Fukuda R, Ichikawa Y, Takaya M, Ogawa Y, Masumoto A. Circadian variations and prednisolone-induced alterations of cirdulating lymphocyte subsets in man. Internal Medicine 33: 733, 1994.
10. Gorla R, Airò P, Franceschini F, et al. Decreased number of peripheral blood CD4+CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. J Rheumatol 17: 1048, 1990.
11. Hinrichsen H, Fölsch U, Kirch W. Modulation of the immune response to stress in patients with systemic lupus erythematosus: review of recent studies. Eur J Clin Invest 22 (suppl 1): 21, 1992.
12. Ichikawa Y, Shimizu H, Yoshida M, Arimori S. B-cells expressing CD5 or activation antigens in the peripheral blood of Sjogren's syndrome, rheumatoid arthritis and systemic lupus erythematosus. Jpn J Clin Immunol 14: 276, 1991
13. Ichikawa Y, Shimizu H, Takahashi K, et al. Lymphocyte subsets of the peripheral blood in Sjögren's syndorome and rheumatoid arthritis. Clin Exp Rheumatol 7: 55, 1989.
14. Jorgensen C, Sany J. Modulation of the immune response by the neuro-endocrine axis in rheumatoid arthritis. Clin Exp Rheumatol 12: 435, 1994.
15. Kimberly RP, Lockshin MD, Sherman RL, McDougal JS, Inman RD, Christian CL. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. AmJ Med 70: 817, 1981.
16. Laxer RM, Stein LD, Petty RE. Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis. Arthritis Rheum 30: 328, 1987.
17. Liebling MR, Leib E, McLaughlin K, et al. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med. 94: 21, 1981.
18. Morimoto C, Steinberg AD, Letvin NL, et al. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79: 762, 1987.
19. Fountain GD, Keogan MT, Hazleman BL, Brown DL. Effects of single dose compared with three days' prednisolone treatment of healthy volunteers: contrasting effects on circulating lymphocyte subsets. J Clin Pathol 46: 1089, 1993.
20. Rota S, Rambaldi A, Gaspari F, et al. Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis. Kidney International 42: 981, 1992.
21. Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab clin Med 101: 479, 1983.
22. Smith MD, Ahern MJ, Brooks PM, Roberts-Thomson PJ, The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. III. Effects on immune and inflammatory indices in synovial fluid. J Rheumatol 15: 238, 1988.
23. Takeuchi T, Tanaka S, Steinberg AD, et al. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. J Clin Invest 82-1288, 1988.
24. Tanaka S, Matsuyama T, Steinberg AD, Schlossman SF, Morimoto C. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. Arthritis Rheum 32: 398, 1989.
25. Williams IA, Baylis EM, Shipley ME. A double blind placebo controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet 2: 237, 1982.